In re Biogen Inc. Securities Litigation

How courts have described this case

Verbatim parenthetical descriptions written by other courts when citing this decision. Ranked by citation-network relevance.

• holding that a company’s statement that it had a “terrific product” was not actionable
• denying “plaintiffs’ informal request for leave to amend” in a securities fraud class action where, instead of “formally request[ing] leave to amend the amended complaint,” plaintiffs requested same “on the final page of their thirty-page opposition to defendants’ motion to dismiss”

Source: CourtListener parenthetical corpus (CC0).